Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05520762 · ClinicalTrials.gov registry record · NA
Hospital Airway Resuscitation Trial
A NA study of Respiratory Failure and Cardiac Arrest, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,060
- Enrollment target
- 1
- Study location
NCT05520762: Recruiting NA study of Respiratory Failure and Cardiac Arrest, sponsored by Montefiore Medical Center.
NCT05520762 is a NA study of Respiratory Failure and Cardiac Arrest that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 1,060 participants, below the 4,497-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05520762, a NA study of Respiratory Failure and Cardiac Arrest, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,060 participants
- Enrollment target
- 1
- Study location
Study Summary
The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.
Primary Outcome
The number of days a patient is alive and breathing independently of invasive mechanical ventilation will be summarized by study arm using basic descriptive statistics. A patient who leaves the hospital alive and is not discharged to a hospice setting, will be considered to have lived to 28-days. A patient discharged to a hospice facility will be assessed as having died on the day of hospital discharge. A patient who is discharged on invasive mechanical ventilation, will be assumed to have remai
Conditions Studied
Interventions
- PROCEDURE A strategy of first choice supraglottic airway
- PROCEDURE A strategy of first choice endotracheal intubation
Study Locations (1)
New York
- Montefiore Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2023-02-10 |
| Est. Completion | 2027-02 |
| Phase | NA |
What NCT05520762 shows while recruiting
NCT05520762 is an interventional study that assigns participants to a tested intervention. Its 1,060 participants enrollment target places it among the larger protocols in the corpus, below the 4,497-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which A strategy of first choice supraglottic airway is the first listed.
NCT05520762 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05520762 about?
NCT05520762 is a clinical study titled "Hospital Airway Resuscitation Trial". The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.
What is the current status of trial NCT05520762?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,060 participants. The study started on 2023-02-10. Estimated completion is 2027-02.
What conditions does trial NCT05520762 study?
This clinical trial studies the following conditions: Respiratory Failure, Cardiac Arrest.
What interventions are being tested in trial NCT05520762?
The interventions under investigation include: A strategy of first choice supraglottic airway (PROCEDURE), A strategy of first choice endotracheal intubation (PROCEDURE).
Who is sponsoring clinical trial NCT05520762?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05520762 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05520762's enrollment target sits among peer trials
1,060 7th of 40 higher than 34 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
-
Low and High Flow Suctioning in Intubated Infants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
- NCT05125302 · 1,059 participants · Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- NCT03588286 · 1,058 participants · NA
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI